Rodrigues Toledo, C.; Tantawy, A.A.; Lima Fuscaldi, L.; Malavolta, L.; de Aguiar Ferreira, C.
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. Int. J. Mol. Sci. 2024, 25, 8553.
https://doi.org/10.3390/ijms25158553
AMA Style
Rodrigues Toledo C, Tantawy AA, Lima Fuscaldi L, Malavolta L, de Aguiar Ferreira C.
EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International Journal of Molecular Sciences. 2024; 25(15):8553.
https://doi.org/10.3390/ijms25158553
Chicago/Turabian Style
Rodrigues Toledo, Cibele, Ahmed A. Tantawy, Leonardo Lima Fuscaldi, Luciana Malavolta, and Carolina de Aguiar Ferreira.
2024. "EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics" International Journal of Molecular Sciences 25, no. 15: 8553.
https://doi.org/10.3390/ijms25158553
APA Style
Rodrigues Toledo, C., Tantawy, A. A., Lima Fuscaldi, L., Malavolta, L., & de Aguiar Ferreira, C.
(2024). EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics. International Journal of Molecular Sciences, 25(15), 8553.
https://doi.org/10.3390/ijms25158553
